Guided Therapeutics, Inc., the developer of the LuViva Advanced Cervical Scan, has announced a new partnership with Hangzhou Dongye Medical Technology Company, Ltd. (HDMT) in China. The company recently completed its initial shipment of devices and single-use components to HDMT. This shipment is part of a larger agreement, including a separate $700,000 purchase order established earlier this year. From the June 27th shipment alone, Guided Therapeutics will recognize an additional $117,462 in sales revenue for Q2 2025. The first batch of three devices from the new order has already been manufactured and tested, prompting an expected $70,000 payment from HDMT in July 2025. HDMT, based in Hangzhou City, Zhejiang Province, is the exclusive provider of gynecology products for 42 hospitals conducting around two million cervical cancer screenings annually.